Limited-Time September Offer: Try 7 Days for Free

Bristol-Myers Squibb (BMY) Stock Price

$46.15 0.4%

Sign up
to add to portfolio

AI Score

  • Alternative

    4
  • Fundamental

    4
  • Technical

    4

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Bristol-Myers Squibb, AI stock picks, stock alerts and much more.

Sign up

BMY AI Stock Analysis

AI stock analysis for BMY is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bristol-Myers Squibb (BMY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Bristol-Myers Squibb (BMY) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bristol-Myers Squibb (BMY), currently trading at $46.15, will... Sign up to access price prediction.

About BMY

LSE
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.

  • Symbol

    BMY

  • Market

    NYSE

  • Industry

    Drug Manufacturers - General

  • Market Cap

    93.9B

Similar Stocks

JNJ Johnson & Johnson
JNJ
$177.2
0.4%
6
LLY Eli Lilly and Company
LLY
$760.1
0.6%
7
PFE Pfizer
PFE
$24.05
0.6%
4
ABBV AbbVie
ABBV
$220.8
2.1%
6
MRK Merck & Company
MRK
$81.14
0.1%
5

BMY Alternative Data

Web Traffic

Bristol-Myers Squibb receives an estimated 948611 monthly visitors to bms.com.

  • Web Traffic

    948611

  • Change from Previous Month

    9.6%

  • 3 Month Change

    20.1%

  • YoY Change

    20.1%

Reddit Mentions

Bristol-Myers Squibb has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Facebook Engagement

Bristol-Myers Squibb has engaged 2,552 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    2552

  • Daily Change

    2.3%

  • 1 Month Change

    50.9%

  • 3 Month Change

    37.7%

  • YoY Change

    37.7%

Instagram Followers

Bristol-Myers Squibb has 0 Instagram Followers on its main Instagram account.

  • Instagram Followers

    0

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Youtube Subscribers

Bristol-Myers Squibb has 6,340 subscribers on its main Youtube channel, up by 24.1% over the last month.

  • Youtube Subscribers

    6340

  • Daily Change

    1%

  • 1 Month Change

    24.1%

  • 3 Month Change

    62.6%

  • YoY Change

    62.6%

LinkedIn Followers

1,705,154 are following Bristol-Myers Squibb on LinkedIn, up by 1.7% over the last month.

  • LinkedIn Followers

    1705154

  • Daily Change

    0.1%

  • 1 Month Change

    1.7%

  • 3 Month Change

    5.2%

  • YoY Change

    5.2%

Job Postings

Bristol-Myers Squibb currenly has an estimated 853 open job postings, up by 10.1% over the last month.

  • Job Postings

    853

  • Daily Change

    1.2%

  • 1 Month Change

    10.1%

  • 3 Month Change

    14.7%

  • YoY Change

    14.7%

LinkedIn Employees

According to LinkedIn, Bristol-Myers Squibb has 38,271 employees, down by -0.3% over the last month.

  • LinkedIn Employees

    38271

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.8%

  • YoY Change

    0.8%

Twitter Followers

Bristol-Myers Squibb has 152,829 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.

  • Twitter Followers

    152829

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Bristol-Myers Squibb is 40 out of 100 (bearish).

  • Business Outlook

    40

  • Change from Previous Month

    4.8%

  • 3 Month Change

    7%

  • YoY Change

    7%

News Mentions

Bristol-Myers Squibb was mentioned 24 times in the news yesterday.

  • News Mentions

    24

  • Daily Change

    84.6%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

BMY Financials

BMY Key Metrics
  • Total Revenue

    $11.2B

  • Net Income

    $2.5B

  • Earnings per Share

    $1.21

  • Free cash flow

    $1.7B

  • EBITDA

    $4.5B

  • EBITDA Ratio

    0.401036

  • Total Assets

    $92.4B

BMY 2-year Revenue & Income
BMY 2-year Free Cash Flow

BMY Technicals

BMY SMA
BMY RSI

FAQ

What's the current price of Bristol-Myers Squibb (BMY) Stock?
The price of an Bristol-Myers Squibb (BMY) share is $46.15.

What's the market cap of Bristol-Myers Squibb?
The current market cap of Bristol-Myers Squibb is 93.9B.

What are some stocks similar to Bristol-Myers Squibb (BMY) that investors often compare it to?
Bristol-Myers Squibb (BMY) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie and Merck & Company.

What is the forecast for Bristol-Myers Squibb's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bristol-Myers Squibb's stock price to be around $44.72 in 2026. Starting from the current price of $46.15, this represents a 3.1% change in price, indicating a neutral outlook for the stock.

How to buy Bristol-Myers Squibb (BMY) Stock?
Bristol-Myers Squibb stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bristol-Myers Squibb shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.